A detailed history of Red Cedar Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Red Cedar Capital, LLC holds 1,180 shares of PFE stock, worth $31,529. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,180
Previous 1,180 -0.0%
Holding current value
$31,529
Previous $52,000 15.38%
% of portfolio
0.04%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

BUY
$43.76 - $53.42 $4,113 - $5,021
94 Added 8.66%
1,180 $52,000
Q2 2022

Aug 02, 2022

BUY
$46.53 - $55.17 $27,266 - $32,329
586 Added 117.2%
1,086 $57,000
Q4 2018

Jan 28, 2019

SELL
$38.47 - $43.86 $7,694 - $8,772
-200 Reduced 28.57%
500 $20,000
Q1 2018

May 07, 2018

SELL
$31.91 - $37.02 $19,146 - $22,212
-600 Reduced 46.15%
700 $25,000
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $43,238 - $45,877
1,300
1,300 $47,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Red Cedar Capital, LLC Portfolio

Follow Red Cedar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Cedar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Cedar Capital, LLC with notifications on news.